A surface molecule on bacteria that instructs bone cells to die could be the target for new treatments for bone disease, says a scientist. Blocking the death signal from bacteria could be a way of treating painful bone infections that are resistant to antibiotics, such as those caused by meticillin-resistant Staphylococcus aureus.